Radiotherapy (RT) is essential in treating abdominal and pelvic cancers but often damages the healthy tissues, particularly the intestines, leading to radiation-induced toxicities with limited treatme...

RadNet (NASDAQ: RDNT) reported strong Q4 2024 financial results with record-breaking performance. Total revenue increased 13.5% to $477.1 million, while Adjusted EBITDA grew 14.0% to $75.0 million compared to Q4 2023. The Digital Health segment showed impressive growth with revenue up 28.1% to $18.9 million.Key operational highlights include:8.0% increase in aggregate procedural volumes4.0% growth in same-center procedural volumesStrong imaging volume growth: MRI +13.4%, CT +13.9%, PET/CT +23.9%Expansion to 398 imaging centers, with 38.4% being joint venture facilitiesThe company maintained a strong financial position with $740 million cash balance and net debt to Adjusted EBITDA ratio under 1.0x. Adjusted Earnings Per Share reached $0.22 in Q4 2024, up from $0.15 in Q4 2023.

Aclarion (NASDAQ: ACON) has announced expansion plans for its Nociscan technology across multiple sites in New York and New Jersey through RadNet affiliates. Lenox Hill Radiology (LHR), operating 79 locations in New York, and New Jersey Imaging Network (NJIN), with 33 locations, will increase Nociscan accessibility in response to growing market demand.The expansion builds on existing Nociscan sites and is facilitated by increased MR Spectroscopy (MRS) availability and enhanced remote operations capabilities within RadNet. LHR Park Avenue serves leading spine physicians from private practices and organizations like Weill Cornell, while NJIN-Union supports both local and out-of-market referrals through convenient airport access.Nociscan is the first evidence-supported SaaS platform that helps physicians noninvasively identify painful discs in the lumbar spine, demonstrating a 97% surgical success rate when all pain-positive discs identified by Nociscan are treated.

PhD Project - Investigating alternative and more effective modes of radiotherapy at University of Birmingham, listed on FindAPhD.com

RadNet (NASDAQ:RDNT – Get Free Report) is projected to announce its Q1 2025 earnings results before the market opens on Monday, May 12th. Analysts expect RadNet to post earnings of ($0.16) per share and revenue of $442.98 million for the quarter. RadNet has set its FY 2025 guidance at EPS. RadNet (NASDAQ:RDNT – Get Free […]

The aim is to use See-Mode's thyroid ultrasound as a way to enhance workflow and diagnostic accuracy at RadNet imaging centers.

Once-rival radiology services firms Imaging Advantage and...